Skip to content
HowShorted

Fulgent Genetics, Inc. short interest in 2025

In 2025, Fulgent Genetics, Inc.'s disclosed short interest ran from 3.48% of shares outstanding on 15 Jan 2025 to 5.06% on 31 Dec 2025, a change of +1.58 percentage points. The year's high was 6.91% on 15 Sep 2025 and its low 3.42% on 31 Jan 2025, averaging 5.62% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.13 days on 29 Aug 2025. Full history: Fulgent Genetics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Fulgent Genetics, Inc. in 2025

2025 in figures

Start of year
3.48% (15 Jan 2025)
End of year
5.06% (31 Dec 2025)
Change
+1.58 pp
High
6.91% (15 Sep 2025)
Low
3.42% (31 Jan 2025)
Average
5.62%
Highest days to cover
11.13 (29 Aug 2025)
SEC filings marked
8

Every report in 2025

Fulgent Genetics, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20253.48%5.39
31 Jan 20253.42%4.28
14 Feb 20254.24%5.31
28 Feb 20254.51%4.8510-K filed, results (8-K)
14 Mar 20255.39%2.54
31 Mar 20254.97%1.87
15 Apr 20255.76%4.14
30 Apr 20255.69%5.51
15 May 20255.81%3.9910-Q filed, results (8-K)
30 May 20255.28%5.46
13 Jun 20255.41%6.68
30 Jun 20256.32%8.73
15 Jul 20256.12%8.81
31 Jul 20256.83%7.01
15 Aug 20256.80%5.0110-Q filed, results (8-K)
29 Aug 20256.71%11.13
15 Sep 20256.91%9.87
30 Sep 20256.33%7.76
15 Oct 20256.24%10.14
31 Oct 20256.13%8.95
14 Nov 20256.04%3.7210-Q filed, results (8-K)
28 Nov 20255.79%5.82
15 Dec 20255.70%8.13
31 Dec 20255.06%8.15

See also: Fulgent Genetics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.